Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Natural killer lymphoma/leukemia: an uncommon pediatric case with indolent course.

Andrea Di Cataldo1, Gregoria Bertuna, Elena Mirabile

  • 1Centre of Paediatric Haematology and Oncology, University of Catania, Via Santa Sofia, 78, 95123 Catania, Italy. adicata@unict.it

Leukemia & Lymphoma
|September 17, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toronto Staging Guidelines for Wilms Tumour: The Meeting Point Between Clinicians and Epidemiologists-Results of the BENCHISTA-ITA Project.

Cancers·2026
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Feasibility of T2-Weighted MRI Radiomics for Initial Risk Stratification in Pediatric Neuroblastoma.

Children (Basel, Switzerland)·2026
Same author

Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013.

Journal of hematology & oncology·2026
Same author

CD19-Negative Acute Lymphoblastic Leukemia (ALL): A Case Report and Review of Literature on a Rare Phenomenon De Novo and a Future Induced Struggle in Relapse.

International journal of molecular sciences·2026
Same author

Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in Italy.

British journal of haematology·2026

This case report details an unusual Epstein-Barr virus-positive Natural Killer (NK) cell lymphoma/leukemia with a prolonged course. The rare cancer presented uniquely, showing good treatment response despite atypical features.

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • Natural killer (NK) cell lymphomas are uncommon malignancies, with geographical variations in incidence.
  • Epstein-Barr virus (EBV) is implicated in the pathogenesis of certain NK cell lymphomas.
  • Pediatric cases of NK cell lymphomas are exceedingly rare.

Observation:

  • A unique case of EBV-positive NK lymphoma/leukemia is presented.
  • The patient exhibited a protracted clinical course with a significant delay between initial symptoms and diagnosis.
  • Neoplastic cells were detected in peripheral blood but absent in bone marrow aspirates.

Findings:

  • The lymphoma/leukemia demonstrated peculiar diagnostic features, including peripheral blood involvement without bone marrow infiltration.

Related Experiment Videos

  • The condition followed an unusually long clinical trajectory.
  • Despite atypical presentation, the neoplastic cells responded well to therapeutic interventions.
  • Implications:

    • This case highlights the diverse clinical and diagnostic spectrum of EBV-positive NK cell lymphomas.
    • Understanding these peculiar features is crucial for accurate diagnosis and effective management of rare hematologic malignancies.
    • Further research into the unique biological behavior of such cases may inform treatment strategies for NK cell lymphomas.